• Yasser M Alatawi, Hala A Alshomrani, Sara M Baeshen, Hayat H Alkhamisi, Roaa M Almazrui, Mohammed S Alghamdi, Sara M Bugshan, Tarik K Alafif, Hussam A Hijazi, Jawaher R Alahmadi, Sawsan A Ashoor, Ahmad M Alamri, and Faris Alkhilaiwi.
• From the Department of Pharmacy Practice (Alatawi), Faculty of Pharmacy, University of Tabuk, Tabuk; from the Department of Natural Products and Alternative Medicine (Alshomrani, Baeshen, Alkhamisi, Almazrui, Alghamdi, Alkhilaiwi), Faculty of Pharmacy, King Abdulaziz University; from the Sheikh Mohammed Hussein Al-Amoudi Center of Excellence in Breast Cancer (Bugshan), King Abdulaziz University; from the Department of Radiology (Hijazi, Alahmadi, Ashoor), Faculty of Medicine, King Abdulaziz University Hospital; from the Regenerative Medicine Unit (Alkhilaiwi), King Fahd Medical Research Center; King Abdulaziz University, Jeddah; from the Computer Science Department (Alafif), Jamoum University College, Umm Al-Qura University, Jamoum; from the Department of Clinical Laboratory Sciences (Alamri), College of Applied Medical Sciences, King Khalid University; from the Cancer Research Unit (Alamri), King Khalid University, Abha, Kingdom of Saudi Arabia.
• Saudi Med J. 2022 Nov 1; 43 (11): 126012641260-1264.

ObjectivesTo evaluate early performance indicators for breast cancer screening at the King Abdulaziz University Hospital in Saudi Arabia.MethodsThis study retrospectively evaluated data from women who underwent their first breast cancer screening program in Jeddah, Saudi Arabia between 2012 and 2019. Data on screening results were used to estimate performance indicators and generate descriptive statistics.ResultsOf the 16000 women invited from 2012 to 2019, a total of 1911 (11.9%) participated. The majority of women (68.8%) were between 40 and 55 years old. Based on the screening process results, 26.6%, 40.1%, 9.7%, 1.3%, 0.7%, and 5.2% of women had BI-RADS scores of R1, R2, R3, R4, R5, and R0 respectively. The remaining 16.3% did not have mammogram records. The recall rate, or the percentage of women who underwent further evaluation, was 19.9%; 18.9% underwent a biopsy procedure. In addition, 1.6% of women had cancer screen-detected, although only 0.7% were diagnosed with breast cancer.ConclusionIn light of the low participation and high recall rates, it is essential that the screening program utilizes performance indicators to optimize resource utilization and ensure the quality of the service provided. Additionally, a national framework and standardized performance indicators could mitigate this problem for other cancer screening programs.Copyright: © Saudi Medical Journal.

18 keywords...

hide…